SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-03-004404
Filing Date
2003-08-14
Accepted
2003-08-14 12:17:14
Documents
5
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b47133aie10vq.htm 10-Q 284171
3 EX-10.1 MASTER SECURITY AGREEMENT b47133aiexv10w1.txt EX-10.1 29817
4 EX-31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b47133aiexv31w1.txt EX-31.1 3695
5 EX-31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER b47133aiexv31w2.txt EX-31.2 3636
6 EX-32.1 CERTIFICATION TO SECT. 906 (CEO & CFO) b47133aiexv32w1.txt EX-32.1 1882
  Complete submission text file 0000950135-03-004404.txt   325310
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 03844870
SIC: 2836 Biological Products, (No Diagnostic Substances)